Vicagrel

General

Type : Not A\/B H target || Drug || Pyridine || Acetate

Chemical_Nomenclature : methyl (2S)-2-(2-acetyloxy-6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)-2-(2-chlorophenyl)acetate

Canonical SMILES : CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3Cl)C(=O)OC

InChI : InChI=1S\/C18H18ClNO4S\/c1-11(21)24-16-9-12-10-20(8-7-15(12)25-16)17(18(22)23-2)13-5-3-4-6-14(13)19\/h3-6,9,17H,7-8,10H2,1-2H3\/t17-\/m0\/s1

InChIKey : GNHHCBSBCDGWND-KRWDZBQOSA-N

Other name(s) : CHEMBL2042273,     SCHEMBL12438770,     ZINC84654546,     AJ-126334


MW : 379.85

Formula : C18H18ClNO4S

CAS_number :

PubChem :

UniChem :

Iuphar :

References (3)

Title : Vicagrel enhances aspirin-induced inhibition of both platelet aggregation and thrombus formation in rodents due to its decreased metabolic inactivation - Jia_2019_Biomed.Pharmacother_115_108906
Author(s) : Jia YM , Ge PX , Zhou H , Ji JZ , Tai T , Gu TT , Zhu T , Li YF , Mi QY , Huang BB , Xie HG
Ref : Biomed Pharmacother , 115 :108906 , 2019
Abstract : Jia_2019_Biomed.Pharmacother_115_108906
ESTHER : Jia_2019_Biomed.Pharmacother_115_108906
PubMedSearch : Jia_2019_Biomed.Pharmacother_115_108906
PubMedID: 31060007

Title : Arylacetamide Deacetylase Is Involved in Vicagrel Bioactivation in Humans - Jiang_2017_Front.Pharmacol_8_846
Author(s) : Jiang J , Chen X , Zhong D
Ref : Front Pharmacol , 8 :846 , 2017
Abstract : Jiang_2017_Front.Pharmacol_8_846
ESTHER : Jiang_2017_Front.Pharmacol_8_846
PubMedSearch : Jiang_2017_Front.Pharmacol_8_846
PubMedID: 29209217

Title : Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase - Shimizu_2014_Drug.Metab.Dispos_42_1103
Author(s) : Shimizu M , Fukami T , Nakajima M , Yokoi T
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 42 :1103 , 2014
Abstract : Shimizu_2014_Drug.Metab.Dispos_42_1103
ESTHER : Shimizu_2014_Drug.Metab.Dispos_42_1103
PubMedSearch : Shimizu_2014_Drug.Metab.Dispos_42_1103
PubMedID: 24751575
Gene_locus related to this paper: human-AADAC , human-CES1 , human-CES2